Skip to content

FREE SHIRT with $80 Purchase (1 per customer)

Cart

Your cart is empty

Continue shopping

BUNDLE & SAVE

SHOP NOW

FREE SHIRT WITH $80 ORDER

ADD TO CART FOR DISCOUNT

SHOP NOW

TESTOSTERONE BOOSTER . . . IS IT RIGHT FOR ME?

supplementsJun 11, 20175 min read

Alfabin™: The Purest Form of Rauwolscine Found in Project M777

If you're on the hunt for the next-level edge in your training, chances are you’ve come across Rauwolscine—a powerful stimulant and alpha-2 antagonist often used for its fat-burning, energy-boosting effects. But not all Rauwolscine is created equal.

Introducing Alfabin™: the trademarked, ultra-pure form of Rauwolscine featured exclusively in Project M777, the elite pre-workout formula by UXO Supplements. No other pre-workout on the market is currently using this premium-grade extract. If you're serious about focus, energy, and thermogenic power, here’s why Alfabin™ deserves your attention..

What is Rauwolscine?

Rauwolscine (also known as alpha-yohimbine) is a compound extracted from the Rauwolfia serpentina plant. It’s structurally similar to Yohimbine, but it’s far more potent—and cleaner in its effects.

As an alpha-2 adrenergic receptor antagonist, Rauwolscine helps increase norepinephrine levels in the body, which:

  • Enhances fat mobilization
  • Increases alertness and energy
  • Supports mood and motivation
  • Acts as a mild appetite suppressant

However, raw Rauwolscine extracts can vary significantly in purity and potency—leading to inconsistent results, and sometimes unwanted side effects like anxiety or jitteriness.

Why Alfabin™ is Different

Alfabin™ isn’t just Rauwolscine. It’s the cleanest, most refined form available—standardized for consistency, efficacy, and purity.

Unlike generic Rauwolscine extracts, Alfabin™ is:

  • Purified for maximum effectiveness
  • Clinically consistent, meaning every dose hits the same
  • Less prone to side effects thanks to reduced impurities
  • Exclusively found in Project M777

The Benefits of Alfabin™ in Project M777

When paired with the full performance matrix of Project M777, Alfabin™ delivers a synergistic edge that hits harder, lasts longer, and helps you stay dialed in from first rep to final set. Here's what to expect:

🔥 Intense Thermogenic Effect

Alfabin™ increases core temperature and ramps up fat oxidation, helping you burn more calories during workouts—especially in fasted states.

⚡ Clean, Sustained Energy

No harsh crashes. The stimulant synergy in M777—with natural caffeine and extended-release stimulants—ensures Alfabin™ gives you smooth, sustained alertness and drive.

🧠 Laser-Like Focus

By elevating norepinephrine and dopamine activity, Alfabin™ enhances mental clarity, alertness, and motivation, helping you get locked into your training.

❌ Appetite Suppression

Alfabin™ can blunt hunger, making it ideal for cutting phases or morning training when you don’t want food weighing you down.

How Alfabin™ Feels in the Gym

Most users report:

  • An intense "tunnel vision" focus
  • Elevated heart rate and clear energy
  • Sweating and thermogenic warmth
  • Slight appetite suppression post-dose
  • Better performance, endurance, and aggression in the gym

If you've used pre-workouts before and felt “flat” or under-stimulated, the addition of Alfabin™ in Project M777 is a game changer.

Why You Won’t Find This Elsewhere

Here’s the truth: most pre-workouts cut corners. They use cheap extracts, outdated ingredient combos, or hide behind proprietary blends.

At UXO Supplements, we’re built different. We don’t follow trends—we lead with transparency, efficacy, and innovation. Alfabin™ is proof of that commitment. And right now, Project M777 is the one of the few pre-workouts on the market using this trademarked, cutting-edge form of Rauwolscine.

Final Thoughts: Is Alfabin™ Right for You?

If you want a pre-workout that delivers clean aggression, relentless energy, and unmatched thermogenic drive, Alfabin™ in Project M777 is for you.

This isn’t your average gym stim. It’s performance-grade, combat-tested, and veteran-formulated. It’s built for those chasing more than a pump—it’s for those building dominance.

PRODUCT DETAILS

50g Serving size at full dose

20/40 servings depending on tolerance

20 active ingredients

6 trademarked ingredients

2 sources of caffeine

5 focus ingredients

includes creatine

max limits of pump ingredients

IS PROJECT M777 RIGHT FOR YOU?

WHAT IS TESTOSTERONE?

Testosterone is the prototypical male hormone. It’s what puts hair on your chest and muscles on your frame during puberty. Put simply, testosterone is what makes a man a man. In healthy men, normal testosterone levels generally range between 300 ng/dL and 1050 ng/dL. Unfortunately, levels decline with aging and may fall below the normal range.

 

TESTOSTERONE LEVELS BY AGE: THE BAD NEWS

As men age, total testosterone levels decline. Even worse, free testosterone (testosterone not bound in the blood to sex hormone-binding globulin (SHBG)) levels decline more rapidly than total testosterone. Studies have shown that total testosterone decreases by approximately 30% in healthy men between the ages of 25 and 75. Free testosterone levels decline even more significantly with decreases of approximately 50%.

 



WHAT PROBLEMS RESULT FROM LOW TESTOSTERONE??


Low testosterone has been correlated with unwanted changes in body composition such as increased abdominal fat and decreased muscle mass. Unfortunately, abdominal fat affects organs like the heart, liver and kidneys more adversely than fat anywhere else, in terms of cardiovascular risk. Unsurprisingly, low testosterone levels are associated with an increased risk of cardiovascular disease and metabolic problems, such as diabetes. Low testosterone can also cause erectile dysfunction, depression, mood changes, and low bone density.

 

WHAT CAN YOU DO ABOUT IT?

TEST BOOST, our natural anabolic enhancer contains the highest quality, most potent, safe, natural compounds available.


TEST BOOST was developed to support the body’s natural (endogenous) production of total testosterone all the way up to high/normal levels, but work in a way that is safe and non-inhibitory.* Supports weight management and healthier bone structures*.



References

1. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. Nov 2002; 87 (11): 5001-5007.

2. Morley JE, Kaiser FE, Perry HM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. Apr 1997 ;46 (4): 410-413.

3. Araujo AB, O’Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. Dec 2004; 89 (12): 5920-5926.

4. Vermeulen A. Declining Androgens with Age: An Overview. In Vermeulen, A. & Oddens, & B. J. (Eds.), Androgens and the Aging Male. 3-14.

5. Simon, D., Nahoul, K., & Charles M.A. (1996). Sex Hormones, Aging, Ethnicity and Insulin Sensivity in Men: An Overview of the TELECOM Study. In Vermeulen, A. & Oddens, and B. J. (Eds.), Androgens and the Aging Male (pp. 85-102).

6. Miner MM. Low Testosterone Medscape CME Expert Column Series. Issue 3: Delivering Safe and Effective Testosterone Replacement Therapy. Medscape Education. 2011.

7. Miner MM, Sadofsky R. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities. Cleveland Clin J Med. 2007;74(suppl 3):S38-S46.

8. Dandona P, Rosenberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract. 2010;64:682-696.

9. Corona G, Rastrelli G, Forti G, Maggi M. Update in testosterone therapy for men. J Sex Med. 2011;8:639-654.

10. Bhasin S, Cunningham GR, Hayes SJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.

11. Anderson RJ, Bergman DA, Garber JR, Hamilton CR, Hershon KS, Jovanovic LG, Kleerekoper M, Mechanick JI, Palumbo PJ, Peters AL, Rettinger HI, Rodbard HW, Rubenstein HA, Seibel JA, Tourtelot JB. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients. AACE Hypogonadism Guidelines, Endocr Pract. 2002; 8 (6): 439-456.

12. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LG, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, and Wu FCW. Investigation, treatment and monitoring of late-onset hypogonadism in males ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008 Nov; 159(5): 507–514.

13. Namiki M, Akaza H, Shimazui T, Ito N, Iwamoto T, Baba K, Kumano H, Koh E, Tsujimura A, Matsumiya K, Horie S, Maruyama O, Marumo K, Yanase T, Kumamoto Y. Clinical Practice Manual for Late-onset Hypogonadism Syndrome. International Journal of Urology. 2008; 15 (5): 377-388.

14. Zitzmann M, Faber S, Nieschlag E 2006 Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335–4343.

15. Kelleher S, Conway AJ, Handelsman DJ 2004 Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89:3813–3817.

16. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. Oct 2005; 26 (6): 833-876.

17. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. Sep 2005; 174 (3): 827-834.

18. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf). Sep 2005; 63 (3): 239-250.

19. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. Jun 2003; 24 (3): 313-340.

20. Pitteloud N, Hardin M, Dwyer AA, et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. May 2005; 90 (5): 2636-2641.

21. Rhoden EL, Morgentaler A. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice. J Sex Med. Jan 2010; 7 (1 Pt 1): 277-283.

22. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. Mar 2005; 90 (3): 1502-1510.

23. Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). Sep 2005; 63 (3): 280-293.

24. Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl. 2009 Nov-Dec 2009; 30 (6): 726-733.

25. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. Jun 2006; 154 (6): 899-906.

26. Chahla EJ, Hayek ME, Morley JE. Testosterone replacement therapy and cardiovascular risk factors modification. Aging Male. Jun 2011; 14 (2): 83-90.

27. Zitzmann M. Testosterone and the brain. Aging Male. Dec 2006; 9 (4): 195-199.

Share

Leave a comment

All comments are moderated before being published.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.